Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · CMS publication 2026-06-30 View official record

Covered recipient · General Payments record

ERIC R MICHAEL

Allopathic & Osteopathic Physicians Psychiatry & Neurology Psychiatry

NPI
1972038388
CMS profile
5254161
Location
LOS ANGELES, CA

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

Saved items

Saved only in this browser. No account or alerts.

Filter and download payment records

General Payments · PY2025 · Entire year

$466.14

16 records · 0 disputed

Summary and payment records

  • CMS publication 2026-06-30
Read the payment records

“Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.”

— Centers for Medicare & Medicaid Services, Open Payments

A reported payment reflects a financial relationship a company disclosed. It does not indicate wrongdoing or a conflict of interest, and it says nothing about the quality of a provider's care.

These records are submitted to CMS and attested to by the reporting companies. CMS publishes them as reported; this site mirrors them without independent verification.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

How these totals are calculated
  • This total is the sum of the individual General Payments record amounts CMS published for the labeled program year(s); each record amount is used unmodified. The total itself is computed by this site. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Methodology & Data — sourcing, labeling, and limitations.

Provider summaries generated . CMS updates this data on an annual cycle, and corrections or successful disputes made at CMS may not yet appear here. The official CMS record is authoritative for the current state. View the official CMS record ↗

By nature of payment

PY2025 · entire year · sorted by reported total

Nature of paymentAmountRecords
Food and Beverage $466.14 16

By paying entity

PY2025 · entire year · sorted by reported total

Page 1 of 1; records 1–16 of 16 matching records. This page contains 16 records (maximum 50), not the full filtered export. Use the CSV download for all matching records.

IndustryPayments · General Payments

ERIC R MICHAEL

NPI 1972038388 · CMS profile ID 5254161

Allopathic & Osteopathic Physicians / Psychiatry & Neurology / Psychiatry

LOS ANGELES, CA

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

General Payments, PY2025; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types

Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00

Page 1 of 1; records 1–16 of 16 matching records. This page contains 16 records (maximum 50), not the full filtered export.

Filtered page: https://industrypayments.org/provider/npi-1972038388?year=2025&recipient=provider#records-h

CMS source: https://openpaymentsdata.cms.gov/dataset/fb0b1734-1410-429d-92f6-3f4b35218e5e

Cite these filtered records

The citation includes this program year, filters, data edition, and page of results.

Plain
ERIC R MICHAEL, NPI 1972038388, CMS profile ID 5254161. General Payments, PY2025; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 1 of 1; records 1–16 of 16 matching records. This page contains 16 records (maximum 50), not the full filtered export. IndustryPayments. https://industrypayments.org/provider/npi-1972038388?year=2025&recipient=provider#records-h. Source: https://openpaymentsdata.cms.gov/dataset/fb0b1734-1410-429d-92f6-3f4b35218e5e.
APA 7
IndustryPayments. (2026). ERIC R MICHAEL, NPI 1972038388, CMS profile ID 5254161. General Payments, PY2025; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 1 of 1; records 1–16 of 16 matching records. This page contains 16 records (maximum 50), not the full filtered export. [Filtered data set page]. https://industrypayments.org/provider/npi-1972038388?year=2025&recipient=provider#records-h. Source: https://openpaymentsdata.cms.gov/dataset/fb0b1734-1410-429d-92f6-3f4b35218e5e.
Bluebook
ERIC R MICHAEL, NPI 1972038388, CMS profile ID 5254161, IndustryPayments, General Payments, PY2025; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types (Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00). Page 1 of 1; records 1–16 of 16 matching records. This page contains 16 records (maximum 50), not the full filtered export. Source: https://openpaymentsdata.cms.gov/dataset/fb0b1734-1410-429d-92f6-3f4b35218e5e. https://industrypayments.org/provider/npi-1972038388?year=2025&recipient=provider#records-h.

Centers for Medicare & Medicaid Services, Open Payments

Citation formats are provided for reference; check the requirements of your publication.

Payment records · PY2025

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

General Payments · PY2025 · Physicians and non-physician practitioners · CMS publication 2026-06-30

16 matching records · $466.14 reported total · 0 disputed

Nature of payment: All payment types

Records imported here (UTC).

Link to these filtered records · CMS source dataset ↗

Download all 16 matching records (CSV)

CSV includes CMS record IDs, source and publication dates, the data edition, and a link to these filters. Formula-like text cells are prefixed with an apostrophe for spreadsheet safety.

Showing records 1–16 of 16.

Paying entityAmountDate Nature of paymentDispute statusPublication flagsPublished Record IDSource
E.R. Squibb & Sons, L.L.C. $29.7512/15/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1184414437 CMS
E.R. Squibb & Sons, L.L.C. $39.9110/15/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1184414433 CMS
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $17.2009/12/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1241365621 CMS
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $23.6509/10/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1241365619 CMS
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $25.1208/01/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1241365617 CMS
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $28.2007/16/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1241365615 CMS
Takeda Pharmaceuticals U.S.A., Inc. $20.0606/25/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1223857905 CMS
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $26.5506/18/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1241365613 CMS
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $119.7606/17/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1241365611 CMS
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $24.5406/03/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1241365609 CMS
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $28.3505/21/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1241365607 CMS
Almatica Pharma LLC $15.5005/12/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1209934461 CMS
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $25.5704/28/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1241365605 CMS
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $18.9903/26/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1241365603 CMS
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $14.0002/28/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1241365601 CMS
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $8.9901/14/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1241365599 CMS

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2019 $116.27 1
PY2023 $34.32 1
PY2024 $133.88 10
PY2025 $466.14 16

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-06-30
Program years on this page
2019, 2023, 2024, 2025
Source files and profile matching
Source files
Dataset page · Bulk file · PY2019 , PY2023 , PY2024 , PY2025
Generated from
OP_DTL_GNRL_PGYR2025_P06302026_06032026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.

Research Payments

One row per program year and role, newest year first · amounts for the two roles are never added together

Program yearRoleAmountRecords
PY2019 Recipient $1,385.20 11

Research Payments are a separate CMS dataset, shown here separately and never added to General Payments. A research payment is often made to an institution, with this provider named as a principal investigator; each record states which role applies.

Research Payments records · PY2019

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

11 records in PY2019

Research Payments records (CSV)

RolePaying entityAmount DateRecipientStudy Dispute statusPublishedRecord ID
Recipient Supernus Pharmaceuticals, Inc. $14.71 12/30/2019 Covered Recipient Physician A PHASE 3, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, MULTICENTER, PARALLEL-GROUP FLEXIBLE-DOSE STUDY OF THE EFFICACY AND SAFETY OF SPN-812 IN ADULTS WITH ATTENTION-DEFICITHYPERACTIVITY DISORDER ADHD No dispute reported 06/30/2026 705877127
Recipient Supernus Pharmaceuticals, Inc. $6.10 12/16/2019 Covered Recipient Physician A PHASE 3, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, MULTICENTER, PARALLEL-GROUP FLEXIBLE-DOSE STUDY OF THE EFFICACY AND SAFETY OF SPN-812 IN ADULTS WITH ATTENTION-DEFICITHYPERACTIVITY DISORDER ADHD No dispute reported 06/30/2026 705877125
Recipient Supernus Pharmaceuticals, Inc. $7.32 11/20/2019 Covered Recipient Physician A PHASE 3, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, MULTICENTER, PARALLEL-GROUP FLEXIBLE-DOSE STUDY OF THE EFFICACY AND SAFETY OF SPN-812 IN ADULTS WITH ATTENTION-DEFICITHYPERACTIVITY DISORDER ADHD No dispute reported 06/30/2026 705877121
Recipient Supernus Pharmaceuticals, Inc. $2.84 11/20/2019 Covered Recipient Physician A PHASE 3, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, MULTICENTER, PARALLEL-GROUP FLEXIBLE-DOSE STUDY OF THE EFFICACY AND SAFETY OF SPN-812 IN ADULTS WITH ATTENTION-DEFICITHYPERACTIVITY DISORDER ADHD No dispute reported 06/30/2026 705877123
Recipient Supernus Pharmaceuticals, Inc. $7.29 11/08/2019 Covered Recipient Physician A PHASE 3, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, MULTICENTER, PARALLEL-GROUP FLEXIBLE-DOSE STUDY OF THE EFFICACY AND SAFETY OF SPN-812 IN ADULTS WITH ATTENTION-DEFICITHYPERACTIVITY DISORDER ADHD No dispute reported 06/30/2026 705877119
Recipient Supernus Pharmaceuticals, Inc. $354.14 10/21/2019 Covered Recipient Physician A PHASE 3, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, MULTICENTER, PARALLEL-GROUP FLEXIBLE-DOSE STUDY OF THE EFFICACY AND SAFETY OF SPN-812 IN ADULTS WITH ATTENTION-DEFICITHYPERACTIVITY DISORDER ADHD No dispute reported 06/30/2026 705877111
Recipient Supernus Pharmaceuticals, Inc. $137.18 10/21/2019 Covered Recipient Physician A PHASE 3, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, MULTICENTER, PARALLEL-GROUP FLEXIBLE-DOSE STUDY OF THE EFFICACY AND SAFETY OF SPN-812 IN ADULTS WITH ATTENTION-DEFICITHYPERACTIVITY DISORDER ADHD No dispute reported 06/30/2026 705877113
Recipient Supernus Pharmaceuticals, Inc. $240.76 10/21/2019 Covered Recipient Physician A PHASE 3, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, MULTICENTER, PARALLEL-GROUP FLEXIBLE-DOSE STUDY OF THE EFFICACY AND SAFETY OF SPN-812 IN ADULTS WITH ATTENTION-DEFICITHYPERACTIVITY DISORDER ADHD No dispute reported 06/30/2026 705877115
Recipient Supernus Pharmaceuticals, Inc. $177.92 10/21/2019 Covered Recipient Physician A PHASE 3, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, MULTICENTER, PARALLEL-GROUP FLEXIBLE-DOSE STUDY OF THE EFFICACY AND SAFETY OF SPN-812 IN ADULTS WITH ATTENTION-DEFICITHYPERACTIVITY DISORDER ADHD No dispute reported 06/30/2026 705877117
Recipient Supernus Pharmaceuticals, Inc. $386.94 09/03/2019 Covered Recipient Physician A PHASE 3, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, MULTICENTER, PARALLEL-GROUP FLEXIBLE-DOSE STUDY OF THE EFFICACY AND SAFETY OF SPN-812 IN ADULTS WITH ATTENTION-DEFICITHYPERACTIVITY DISORDER ADHD No dispute reported 06/30/2026 705877107
Recipient Supernus Pharmaceuticals, Inc. $50.00 09/03/2019 Covered Recipient Physician A PHASE 3, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, MULTICENTER, PARALLEL-GROUP FLEXIBLE-DOSE STUDY OF THE EFFICACY AND SAFETY OF SPN-812 IN ADULTS WITH ATTENTION-DEFICITHYPERACTIVITY DISORDER ADHD No dispute reported 06/30/2026 705877109